Cytoreductive Surgery and Peritonectomy Procedures
By: Dr. Sanket Mehta
Authors: Aditi Bhatt, Olivier Glehen
Journal: Indian Journal of Surgical Oncology
Start: February 3, 2016
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has become widely accepted as an effective method of treating peritoneal metastases (PM) from various cancers. CRS performed with the goal of removing all the macroscopic disease and comprises of peritonectomy procedures and visceral resections.
CRS is a technically challenging surgery that requires a considerable amount of skill and appropriate patient selection. This article is a review of the techniques and current recommendations for performing CRS.